Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) 是一家上市公司 属于 医疗保健 板块，经营于 Medical - Pharmaceuticals 行业. 公司总部位于 Nashville, DE, 美国. 现任CEO为 Mark L. Baum.
HROWL 拥有 IPO日期为 2021-05-07, 217 名全职员工, 在 NASDAQ Global Market, 市值为 $1.37B.
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
